New York State Department Of Health

Buyer seeks to fund translational research projects in spinal cord injury. Buyer aims to accelerate the translation of basic findings into clinical benefits for spinal cord-injured persons. Buyer will support projects that advance early translational findings into mid/late-stage translational and pre-clinical research. Buyer encourages applications that include or lead to Phase I and Phase II clinical trials. Buyer requires detailed translational plans from the starting point to envisioned patient health outcomes.

• 12/11/2024 - Letter of Interest Due
• 12/17/2024 - Applicant Conference
• 12/24/2024 - Questions Due
• 1/22/2025 - Proposal Due Date

• Applicant must be a not-for-profit or governmental organization in New York State
• Principal Investigator must not be a postdoctoral fellow or dependent research staff
• Application must not propose support for a research center or Phase III clinical trial

• Conduct translational research on spinal cord injury treatments
• Develop clinical applications for spinal cord injury cures
• Validate and optimize devices and technologies for treating spinal cord injury
• Conduct Phase I and Phase II clinical trials
• Collaborate with research institutions, businesses and regulatory agencies
• Develop commercialization plans for spinal cord injury treatments
• Implement GMP, GLP, GCLP and GCP compliance standards
• Establish quantifiable milestones and decision points
• Provide patient monitoring beyond the contract term if conducting clinical trials
• Prepare progress reports and a final cumulative report